Search the Newsreel

Are Wall Street Analysts Bullish on Zimmer Biomet Stock?

Zimmer Biomet headquarters_By jetcityimage Zimmer Biomet Holdings, Inc. (ZBH), headquartered in Warsaw, Indiana, designs, manufactures, and sells medical equipment. Valued at $18.7 billion by market cap, the company offers orthopedic, dental, and spinal reconstructive implants, as well as bone cement and related surgical products. …

5 Revealing Analyst Questions From Zimmer Biomet’s Q2 Earnings Call

5 Revealing Analyst Questions From Zimmer Biomet's Q2 Earnings Call Zimmer Biomet's second quarter results were driven by strong execution in its hip franchise, robust technology sales, and progress in the U.S. sales force transformation. CEO Ivan Tornos highlighted that new product adoption, such …

Handelsbanken Fonder AB Buys 28,130 Shares of Zimmer Biomet Holdings, Inc. $ZBH

Handelsbanken Fonder AB increased its stake in Zimmer Biomet Holdings, Inc. by 22.7% in the second quarter, purchasing an additional 28,130 shares to bring its total to 152,064 shares valued at approximately $13.1 million. Zimmer Biomet exceeded Q2 earnings expectations with $2.07 EPS and …

Zimmer Biomet (ZBH) sees Dodge & Cox disclose 12.5% ownership stake

Dodge & Cox has filed an amended Schedule 13G, revealing a 12.5% beneficial ownership stake in Zimmer Biomet Holdings, Inc. (ZBH), as of June 30, 2026. This represents 24,124,735 shares, with Dodge & Cox holding sole voting power over 22,808,935 shares and sole dispositive …

Will Zimmer Biomet’s Upgraded 2026 Guidance and Buyback Shift Zimmer Biomet Holdings’ (ZBH) Narrative

Zimmer Biomet Holdings (ZBH) reported strong Q2 2026 results, including US$2,177 million in sales and US$198.3 million in net income, alongside completing a US$496.84 million share buyback. Management also raised full-year guidance due to robust performance in its hip and technology segments. This move …

Zimmer Biomet reports strong second quarter financial results

Zimmer Biomet Holdings Inc. announced strong financial results for the second quarter of 2026, with net sales increasing by 4.8% to $2.177 billion and adjusted diluted earnings per share at $2.07. The company is raising its revenue and adjusted EPS guidance for the year …

Zimmer Biomet (ZBH): Capital International Investors reports 6.4% ownership stake

Capital International Investors has reported a 6.4% ownership stake in Zimmer Biomet Holdings, Inc. (ZBH), totaling 12,438,366 shares. This passive investment grants them sole voting power over 12,279,364 shares and sole dispositive power over all 12,438,366 shares, as detailed in a Schedule 13G SEC …

Zimmer Biomet (ZBH) Q2 2026 Earnings Call Transcript

Assenagon Asset Management S.A. Buys 97,887 Shares of Zimmer Biomet Holdings, Inc. $ZBH

Assenagon Asset Management S.A. significantly increased its stake in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) during the second quarter, purchasing an additional 97,887 shares to bring its total holdings to 102,862 shares valued at $8.855 million. This comes as Zimmer Biomet reported strong quarterly earnings, …

Zimmer Biomet Holdings Inc. stock outperforms competitors on strong trading day

Zimmer Biomet Holdings Inc. (ZBH) saw its stock advance by 1.27% to $97.78 on Monday, outperforming the broader market which experienced a dismal trading session. This rise broke a two-day losing streak for the company's shares. The S&P 500 Index and Dow Jones Industrial …

Zimmer Biomet (NYSE:ZBH) Price Target Raised to $100.00

Canaccord Genuity raised Zimmer Biomet's (NYSE:ZBH) price target from $83.00 to $100.00 while maintaining a "hold" rating, suggesting a 3.59% upside. The medical equipment provider recently reported strong quarterly earnings, beating EPS estimates by $0.06 and achieving a 4.8% year-over-year revenue increase. Analysts, on …

Price to earnings forward of Zimmer Biomet Holdings, Inc. – BX:ZIM

The article presents the "Price to earnings forward" value for Zimmer Biomet Holdings, Inc. (BX:ZIM) on TradingView. It appears to be a financial data point for the company, indicating its valuation based on future earnings expectations. The page also includes various navigation and information …

Zimmer Biomet Q2 Earnings Call Highlights

Key Points Interested in Zimmer Biomet Holdings, Inc.? Here are five stocks we like better. Zimmer Biomet reported solid Q2 growth: Net sales rose 4.8% to $2.177 billion, driven by hips, specialty businesses and technology. Adjusted EPS was $2.07, while U.S. organic sales increased …

Zimmer Biomet Holdings, Inc. (ZBH) Stock Price, News, Quote & History

This Yahoo Finance page provides a comprehensive overview of Zimmer Biomet Holdings, Inc. (ZBH) stock, including its current price, news, and historical data. It notes a recent downgrade by BTIG due to growth challenges and presents performance metrics against the S&P 500. The article …

Wilsey Asset Management Inc. Has $36.32 Million Stake in Zimmer Biomet Holdings, Inc. $ZBH

Wilsey Asset Management Inc. increased its stake in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) by 4.7% in the second quarter, bringing its total holdings to 421,867 shares valued at $36.32 million. The medical equipment provider recently reported strong Q2 earnings, beating analyst estimates with $2.18 …

Zimmer Biomet Holdings (ZBH) Following Its Beat And Guidance Lift, Is The Valuation Catching Up?

Zimmer Biomet Holdings (ZBH) recently reported stronger-than-expected quarterly results and increased its guidance, driven by solid execution in U.S. hip and technology lines and sales force restructuring progress. Despite a significant 5-year decline in shareholder return, the company's recent 90-day share price return of …

Zimmer Biomet (ZBH) Stock Gets Fair Value Bump After Mixed Analyst Views

Zimmer Biomet Holdings (ZBH) has seen its fair value updated by analysts, with some taking a bullish stance due to undervaluation and growth opportunities, while others remain cautious, emphasizing consistent execution and margin stabilization. The company's fair value moved from US$98.70 to approximately US$102.19, …

Zimmer Biomet Holdings, Inc. Stock 12‑Month Price Target Raised to $104.9, Implies 7% Upside

Zimmer Biomet Holdings, Inc.'s average price target has been increased to $104.9, up from $104.26, according to 20 analysts. This updated target suggests a potential 7% upside based on the Aug. 5 closing price. The consensus rating among 29 analysts remains a "Buy," with …

JPMorgan Adjusts Price Target on Zimmer Biomet to $117 From $95

JPMorgan has raised its price target for Zimmer Biomet Holdings, Inc. (ZBH) to $117 from $95. This adjustment was reported on August 6, 2026, at 12:02 pm EDT. The article also notes several other analyst adjustments for Zimmer Biomet on the same day.

UBS Adjusts Price Target on Zimmer Biomet to $120 From $115, Maintains Buy Rating

UBS has increased its price target for Zimmer Biomet Holdings, Inc. (ZBH) to $120 from $115, while reaffirming a Buy rating on the stock. This adjustment comes amidst other analyst revisions for Zimmer Biomet on the same day, indicating active re-evaluation of the company's …

Zimmer Biomet sales force revamp going better than expected, CEO says

Zimmer Biomet's CEO Ivan Tornos announced that the company's transition to a fully dedicated sales force is progressing better than anticipated, leading to increased sales and earnings expectations for 2026. The restructuring, involving a shift of 2,500 U.S. sales personnel to dedicated specialists, has …

Deutsche Bank Adjusts Zimmer Biomet Price Target to $98 From $88, Maintains Hold Rating

Deutsche Bank has adjusted its price target for Zimmer Biomet Holdings, Inc. (ZBH) to $98, up from $88, while maintaining a "Hold" rating on the stock. This update reflects recent market activity and analyst assessments. The article also notes other analyst revisions for Zimmer …

Zimmer Biomet (ZBH) Stock Gains Ground While Margins Tighten

ZIMMER BIOMET HOLDINGS, INC. : STIFEL RAISES TARGET PRICE TO $110 FROM $105

Stifel has increased its target price for Zimmer Biomet Holdings, Inc. (ZBH.N) to $110 from $105. This adjustment reflects a change in the financial outlook or valuation assessment by the analyst firm for the medical technology company. The article, sourced from Reuters, reports this …

Earnings Flash (ZBH) Zimmer Biomet Holdings, Inc. Posts Q2 Adjusted EPS $2.07 per Share, Vs. FactSet Est of $2.01

Zimmer Biomet Holdings, Inc. (ZBH) reported strong second-quarter adjusted earnings per share of $2.07, surpassing the FactSet estimate of $2.01. The company's revenue also exceeded expectations, coming in at $1.85 billion against an estimated $1.81 billion. This positive performance indicates a strong financial quarter …

Zimmer Biomet Holdings Inc (ZBH) (Q2 2026) Earnings Call Highlights: Strong Sales Beat and Raised Guidance Amid Strategic Investments

Zimmer Biomet Holdings Inc (ZBH) reported strong Q2 2026 results, exceeding expectations with $2.177 billion in net sales and 4% organic constant currency growth, primarily driven by robust US performance in the hips segment and technology. The company raised its full-year 2026 revenue and …

Zimmer Biomet (NYSE: ZBH) awards 10,168 RSUs to President, APAC

Zimmer Biomet Holdings, Inc. (NYSE: ZBH) has awarded 10,168 restricted stock units (RSUs) to Chintan Desai, President, APAC. These RSUs represent a contingent right to one share of common stock each, with one-third vesting on August 3rd of 2027, 2028, and 2029. Following this …

Needham reiterates Hold on Zimmer Biomet stock after Q2 beat

Needham has reiterated a Hold rating on Zimmer Biomet Holdings Inc. (NYSE:ZBH) after the medical device company surpassed second-quarter revenue and EPS expectations. Despite strong gross profit margins and anticipated net income growth, the firm maintains its Hold rating due to expected challenges in …

Zimmer Biomet Holdings Releases Q2 2026 Financial Results

Zimmer Biomet Holdings reported strong Q2 2026 financial results, surpassing Wall Street expectations with adjusted earnings of $2.07 per share and revenue of $2.18 billion. The medical technology company showed consistent growth across its product lines and provided a full-year adjusted EPS projection of …

Zimmer Biomet reports 4.8% YoY revenue uptick in Q2; raises 2026 outlook

Zimmer Biomet has reported Q2 revenues of around $2.18bn, denoting a year-over-year (YoY) uptick of 4.8%, and a revised full year outlook. Zimmer's knees segment was its strongest performer in Q2, with sales totalling $828.9m, followed by S.E.T. (Sports Medicine, Extremities, Trauma, Craniomaxillofacial and …

[ZBH Q2 2026 Earnings Call] Zimmer Biomet Beats and Raises as Hip, Tech Sales Surge; U.S. Technology Revenue Jumps 53%

Zimmer Biomet exceeded Q2 2026 expectations, driven by strong hip and technology sales, leading to a raised full-year guidance. The company reported a 4.8% increase in net sales and a 53% jump in U.S. technology revenue, alongside significant growth in hip sales. CEO Iván …

Earnings call transcript: Zimmer Biomet lifts 2026 outlook after Q2 beat

Zimmer Biomet (ZBH) reported strong second-quarter 2026 results, beating Wall Street expectations for both earnings and revenue, leading the company to raise its full-year 2026 outlook. The orthopedic-device maker saw significant growth in hip sales, technology and data, and its S.E.T. business, with its …

Transcript : Zimmer Biomet Holdings, Inc., Q2 2026 Earnings Call, Aug 05, 2026

This article provides the transcript of Zimmer Biomet Holdings, Inc.'s Q2 2026 Earnings Call from August 5, 2026. The content is primarily a record of the conference call proceedings, including the operator's message and an invitation for subscribers to access the full transcript. The …